Showing 1 - 10 of 117
Nose for business: Smell, sell, repeat in Thai laundry culture
Nonthawat Phakham, Published on 28/01/2026
» Have you ever felt confused buying fabric softener or detergent in Thailand? I have. Choosing these products is no longer just about scent. They now offer features like UV protection, night-dry and indoor-dry formulas, quick or expert wash options, fast-wash, anti–colour-transfer technology and multiple scent variations for each formula.
Doom missed again
Oped, Postbag, Published on 04/11/2025
» Re: "Forget the gloom", (PostBag, Oct 31) & "Thailand now 'the sick man of Asean'", (Opinion, Oct 30).
China expands grip on wind energy
News, Ron Bousso, Published on 30/10/2025
» European governments seeking to expand offshore wind power are increasingly wary of Chinese companies' involvement. Countering China's dominance will be time-consuming and expensive, but political pressure and national security concerns may give the region little choice.
Breaking barriers for Thai innovations
Oped, Saowaruj Rattanakhamfu and Pichakorn Khowasinth, Published on 27/08/2025
» Thailand is abundant with talent in medical technology. Why aren't our homegrown innovations reaching patients? The answer is simple: a broken system.
Can Europe, China forge a climate connection?
Oped, Emmanuel Guerin & Bernice Lee, Published on 12/08/2025
» Earlier this year, the Chinese firm CATL, the world's largest battery-maker, unveiled an electric-vehicle (EV) battery capable of delivering a remarkable 520 kilometres (323 miles) of driving range after just five minutes of charging. The announcement came a month after BYD, China's leading EV manufacturer, launched its own ultra-fast charging system. In solar, too, the numbers are staggering: Chinese firms can now produce over 1,200 gigawatts of solar panels annually.
Unite to solve neglected diseases
Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025
» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.
Buyback binge
Oped, Postbag, Published on 28/03/2025
» Re: "Twenty listed firms seen likely to prep share buybacks", (Business, March 25).
Zelensky-Trump clash spurs rethink by US allies
News, Peter Apps, Published on 10/03/2025
» As they watched Ukrainian President Volodymyr Zelensky evicted from the White House last week after an unprecedented live televised quarrel with President Donald Trump and his Vice President JD Vance, some of America's closest allies began to swiftly reappraise decades of foreign and defence policy.
Trump's tariffs will hit consumers and businesses
News, Nancy Qian, Published on 27/02/2025
» The opening salvos of US President Donald Trump's trade war have sent shockwaves around the world. Over the past weeks, his administration has broken with decades of free-trade orthodoxy, threatening to impose tariffs not only on strategic adversaries like China but also on longstanding allies like Canada and Mexico.
Pollution puzzle
Postbag, Published on 07/02/2025
» Re: "Pulling a cure out of thin air", (Business, Feb 3).